TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
RGC

Regencell Bioscience Holdings Ltd

Healthcare · Drug Manufacturers - Specialty & Generic

6.20$ +0.0% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement RGC
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% – – – – – – –
3.7% 3.7% 38.6% 38.4% 3.9% – – – – – – –
96.3% 96.3% 61.4% 61.6% 96.1% – – – – – – –
2.4% 2.5% 16.0% 16.0% 2.7% – – – – – – –
38.1% 39.9% 50.5% 50.9% 41.4% – – – – – – –
11.2% 10.2% 10.8% 10.8% 8.6% – – – – – – –
– – – 0.0% 0.0% – – – – – – –
8.7% 6.0% 8.1% 8.8% 6.8% – – – – – – –
3.5% 2.5% 3.2% 3.5% 3.2% – – – – – – –
5.2% 3.5% 4.9% 5.3% 3.6% – – – – – – –
15.4% 13.1% 15.0% 16.0% 14.8% – – – – – – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?